Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of TP-1287 in Patients with Sarcoma

Nov 03, 2021

Posted by Sumitomo Pharma Oncology, Inc.

eClinical Solutions Enhances elluminate Clinical Data Cloud with RBQM

Nov 03, 2021

Diversity of Investigative Site Staff Highly Associated with the Diversity of Patients Enrolled in Clinical Trials, According to Tufts Center for the Study of Drug Development

Nov 03, 2021

Posted by Tufts University

Nucleic acid delivery: Are you developing what Big Pharma seeks?

Nov 02, 2021

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma

Oct 26, 2021

Posted by Sumitomo Pharma Oncology, Inc.

Finding Success as a Scientist: Women and Diversity in Science with Cierra Spencer

Oct 26, 2021

Posted by UCB

Certara Blog: A Day in the Life of a Clinical Pharmacology Consultant

Oct 26, 2021